Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience

被引:0
作者
Rocha, F. [1 ]
Stocchi, F. [2 ]
Lees, A. [3 ]
Ferreira, J. [4 ]
Poewe, W. [5 ]
Rascol, O. [6 ]
Santos, A. [7 ]
Magalhaes, D. [1 ]
Soares-da-Silva, P. [7 ]
机构
[1] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[2] IRCCS San Raffaele, Dept Neurol, Rome, Portugal
[3] Natl Hosp Neurol & Neurosurg, Dept Neurol, London, England
[4] Univ Lisbon, Dept Neurol, Fac Med, Lisbon, Portugal
[5] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[6] Univ Hosp Toulouse, Dept Neurol, Toulouse, France
[7] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
关键词
LEVODOPA; ADJUNCT;
D O I
10.1016/j.jns.2019.10.1151
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
WCN19-0301
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Influence of disease duration in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Ferreira, J.
    Lees, A.
    Antonini, A.
    Rascol, O.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 656 - 656
  • [22] Influence of disease duration in the efficacy response of Parkinson's disease patients with motor fluctuations: post-hoc analysis from combined BIPARK-I and II
    Gama, H.
    Ferreira, J.
    Lees, A.
    Antonini, A.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S41 - S41
  • [23] Influence of disease severity in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Antonini, A.
    Gama, H.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [24] Efficacy of opicapone in Parkinson's disease patients according to baseline rasagiline use: a post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Tolosa, E.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S57 - S57
  • [25] Efficacy of opicapone in Parkinson's disease patients according to baseline rasagiline use: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Tolosa, E.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 653 - 653
  • [26] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [27] Efficacy of opicapone in Parkinson's disease patients according to baseline pramipexole use: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Santos, A.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [28] Influence of demographic characteristics in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Ferreira, J.
    Lees, A.
    Reichmann, H.
    Poewe, W.
    Ikedo, F.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    Savic, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [29] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 652 - 652
  • [30] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: a post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S56 - S57